Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Clinical trial NCT01368263 · TERMINATED

Trial details

NCT number: NCT01368263
Sponsor: Washington University School of Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor-positive Breast Cancer HER2-negative Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer

Start date: 2011-09-01
Primary completion: 2013-05-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.